Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial
Phase: PHASE1 | Sponsor: Centre for Addiction and Mental Health | Compound: Psilocybin
- Status
- recruiting
- Institution
- Centre for Addiction and Mental Health
- Start date
- 2024-09-01
- End date
- 2025-10-01
- Registry ID
- NCT06299319
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.